本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Tscan Therapeutics, Inc.

0.7937
-0.0056-0.70%
盤後0.79370.00000.00%16:10 EDT
成交量:18.06萬
成交額:14.39萬
市值:5,379.64萬
市盈率:-0.88
高:0.8111
開:0.7924
低:0.7774
收:0.7993
52周最高:2.57
52周最低:0.7160
股本:6,777.93萬
流通股本:5,781.86萬
量比:0.63
換手率:0.31%
股息:- -
股息率:- -
每股收益(TTM):-0.9000
每股收益(LYR):-2.2805
淨資產收益率:-95.80%
總資產收益率:-31.53%
市淨率:0.78
市盈率(LYR):-0.35

資料載入中...

2024/08/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/12

重要事件披露

Form 8-K - Current report
2024/06/14

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/06/14

重要事件披露

Form 8-K - Current report
2024/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/13

重要事件披露

Form 8-K - Current report
2024/04/29

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/23

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/17

重要事件披露

Form 8-K - Current report
2024/04/17

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/04/16

重要事件披露

Form 8-K - Current report
2024/04/10

SEC問詢函

Form CORRESP - Correspondence
2024/04/10

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/04/08

重要事件披露

Form 8-K - Current report
2024/03/06

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/06

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/06

重要事件披露

Form 8-K - Current report
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]